Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

NCT00001119 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

288

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: Tetanus Toxoid Vaccine
DRUG: Indinavir sulfate
DRUG: Lamivudine/Zidovudine
DRUG: Ritonavir
DRUG: Abacavir sulfate
DRUG: Amprenavir
DRUG: Efavirenz
BIOLOGICAL: Hepatitis B Vaccine (Recombinant)
DRUG: Lamivudine
DRUG: Zidovudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)